How to report an adverse event
Εάν εσείς ή κάποιος δικός σας παρουσιάσετε ανεπιθύμητη ενέργεια από προϊόν του χαρτοφυλακίου μας, παρακαλούμε όπως μας ενημερώσετε άμεσα, μέσω ενός από τους παρακάτω τρόπους:
-
Phone: +30 210 3511771 (Pharmacovigilance ext.)
-
Online form
-
By post: PromoPharma S.A., Attn: Pharmacovigilance Department, 3 Kifisias Ave., 151 23 Marousi, Athens.
Information to include
-
Product name and dosage
-
Description of the adverse event
-
Start date and duration
-
Your contact details (optional, for follow-up)
Important notice:
Information you share with us is treated with strict confidentiality and is used exclusively for pharmacovigilance purposes, in accordance with the General Data Protection Regulation (GDPR).
Reporting to the Greek NCA
You may also report an adverse event directly to the Greek National Organisation for Medicines (EOF) through the Yellow Card system at www.eof.gr.
Patient safety is our first priority.
Pharmacovigilance is the scientific and operational activity related to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. At PromoPharma, pharmacovigilance is not a support function — it is one of the foundational pillars of our corporate operation.
